This is a preview of subscription content, log in via an institution to check access.
Notes
Efficacy and Safety Trial Evaluating the Effects of apreMilast in psoriasis
Comparative study of HumirA vs. Methotrexate vs Placebo In psOriasis patieNts
2015 US dollars
Reference
Armstrong AW, et al. Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naive patients with psoriasis. Journal of the American Academy of Dermatology : 28 Jul 2016. Available from: URL: http://doi.org/10.1016/j.jaad.2016.05.040
Rights and permissions
About this article
Cite this article
Apremilast not cost effective versus methotrexate for psoriasis. PharmacoEcon Outcomes News 759, 10 (2016). https://doi.org/10.1007/s40274-016-3275-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3275-y